The identification of multiple mutations in our study, including KRAS G12C, EGFR Exon 20, ERBB2, MET exon 14 skipping, ALK, ROS1, RET fusions, and BRAF V600E, reflects the molecular heterogeneity of NSCLC. This evidence concerns the gene EGFR and non-small cell lung carcinoma.